MRNA Oct 2024 170.000 call
| Previous Close | 8.45 |
| Open | 16.35 |
| Bid | 20.10 |
| Ask | 20.55 |
| Strike | 170.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 16.35 - 20.80 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 220 |
BloombergHuman Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock in vaccine developers. It’s a familiar setup for industry veterans who have witnessed past trading frenzies at the first signs of an outbreak. Most Read from BloombergThese Flight Routes Suffer the World’s Worst TurbulenceCiti Trader Got 711 Warning Messages Before Sparking Flash CrashOne Dead After Singapore Air Flight Hit By Severe TurbulenceBarclays Managers Warn Some Staff to Prepare for Five
ACCESSWIREModerna Announces Data to be Presented at 2024 ASCO Annual Meeting
Moderna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT CAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on mRNA-4157 (V940), an investigational mRNA individualized ...
ZacksSanofi (SNY) Signs Deal for AI-Powered Drug Development
Sanofi (SNY) inks collaboration deal with Formation Bio and OpenAI to build AI-powered software to advance drug development and create new medicines.
